Skip to main content
. 2019 Feb 25;9:2728. doi: 10.1038/s41598-019-39565-9

Figure 4.

Figure 4

HtrA4 inhibits primary EPC proliferation. EPCs were treated with vehicle control or two doses of HtrA4 over 48 h. (a) Growth curve. (b) Percentage of viable cells. (c) Immunofluorescence of cell proliferation marker Ki67 at 24 h, representative images at 10x magnification are shown. (d) Quantification of Ki67 staining of (c). n = 4. Data is expressed as mean ± SD. *p < 0.05; **p < 0.01, ****p < 0.0001.